ArticlePharmaceutics2026

Feasibility Study of Nose-to-Brain Delivery of Galantamine for Alzheimer's Disease: Enhancing Olfactory-Region Deposition to Improve Therapeutic Efficacy.

Chuangxin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.